>We certainly are not going to allocate a scarce valuable resource according to ability to pay. That’s crazy talk.
Indeed, when talking about a vaccine that is crazy.
As an ‘initial move’ in the pandemic game, I sympathize with allocating-via-money as ‘crazy’. But not doing that also has a significant opportunity cost long-term, e.g. foregoing resources for further production of vaccines that people want.
This is what ‘public goods’ with strong positive externalities provided by governments paying the vaccine companies are for.
>We certainly are not going to allocate a scarce valuable resource according to ability to pay. That’s crazy talk.
Indeed, when talking about a vaccine that is crazy.
As an ‘initial move’ in the pandemic game, I sympathize with allocating-via-money as ‘crazy’. But not doing that also has a significant opportunity cost long-term, e.g. foregoing resources for further production of vaccines that people want.
This is what ‘public goods’ with strong positive externalities provided by governments paying the vaccine companies are for.